Patents by Inventor Knud J. Jensen

Knud J. Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10570177
    Abstract: Herein provided are peptide inhibitors and methods for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for therapeutic use in the treatment of polyQ diseases.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: February 25, 2020
    Assignees: The Chinese University of Hong Kong, University of Copenhagen
    Inventors: Ho Yin Edwin Chan, Knud J. Jensen, Jacky Chi Ki Ngo, Kasper K Sorensen, Qian Zhang, Zhong Zuo
  • Publication number: 20180251493
    Abstract: The present invention provides for novel peptide inhibitors and methods for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for therapeutic use in the treatment of polyQ diseases.
    Type: Application
    Filed: February 13, 2018
    Publication date: September 6, 2018
    Inventors: Ho Yin Edwin CHAN, Knud J. Jensen, Jacky Chi Ki Ngo, Kasper K. Sorensen, Qian Zhang, Zhong Zuo
  • Patent number: 9187547
    Abstract: The present invention relates to human insulin analogues containing a substituting cysteine, to human insulin derivatives containing a PEGylated substituting cysteine and methods of making such. The compounds of the invention may be useful for the treatment of diabetes.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: November 17, 2015
    Assignee: Novo Nordisk A/S
    Inventors: Tine Nygaard Vinther, Thomas Boerglum Kjeldsen, Frantisek Hubalek, Knud J. Jensen
  • Publication number: 20140031279
    Abstract: The present invention relates to human insulin analogues containing a substituting cysteine, to human insulin derivatives containing a PEGylated substituting cysteine and methods of making such. The compounds of the invention may be useful for the treatment of diabetes.
    Type: Application
    Filed: March 15, 2012
    Publication date: January 30, 2014
    Applicants: UNIVERSITY OF COPENHAGEN, NOVO NORDISK A/S
    Inventors: Tine Nygaard Vinther, Thomas Boerglum Kjeldsen, Frantisek Hubalek, Knud J. Jensen
  • Publication number: 20030138880
    Abstract: The present invention provides materials and methods for the solid-phase synthesis of oligosaccharides and glycopeptides. Such materials and methods include mutant glycosidase enzymes, or “glycosynthases,” chemically-derivatized acceptor molecules, and specific solid support matrices.
    Type: Application
    Filed: August 26, 2002
    Publication date: July 24, 2003
    Applicant: University of British Columbia
    Inventors: Stephen G. Withers, Knud J. Jensen, Lars Petersen, Jakob L. Tolborg
  • Patent number: 6566494
    Abstract: A support material for solid phase synthesis is provided having an amine-containing organic group attached to it through a linker.
    Type: Grant
    Filed: May 11, 1999
    Date of Patent: May 20, 2003
    Assignee: Regents of the University of Minnesota
    Inventors: Knud J. Jensen, George Barany, Micheal F. Songster, Fernando Albericio, Jordi Alsina, Josef Vágner
  • Patent number: 5917015
    Abstract: A support material for solid phase synthesis is provided having an amine-containing organic group attached to it through a linker.
    Type: Grant
    Filed: June 18, 1996
    Date of Patent: June 29, 1999
    Assignee: Regents of the University of Minnesota
    Inventors: Knud J. Jensen, George Barany, Micheal F. Songster, Fernando Albericio, Jordi Alsina, Josef Vagner